Cargando…

Antibacterials/antivirals: Off-label use in COVID-19 pneumonia, and induction of resistance through mutation selection: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501318/ http://dx.doi.org/10.1007/s40278-021-03290-0

Ejemplares similares

Antibacterials/antivirals/immunosuppressants: COVID-19 infection, COVID-19 pneumonia and off-label use: 7 case reports
Publicado: (2022)

Antibacterials/antivirals: Erythema multiforme and off label use: 2 case reports
Publicado: (2020)

Antibacterials/antivirals/dexamethasone: Aspergillus terreus infection, lack of efficacy and off label use: case report
Publicado: (2021)

Antivirals/immunosuppressants: COVID-19 infection and off label use: case report
Publicado: (2020)

Antibacterials/antivirals: QTc-interval prolongation and cardiac arrest following off-label therapy: 3 case reports
Publicado: (2021)

Dexamethasone/favipiravir/antibacterials: Cytomegalovirus pneumonia, Candida parapsilosis infection and off label use: case report
Publicado: (2021)

Cladribine/hydroxychloroquine: COVID-19-pneumonia, lymphopenia and off label use: case report
Publicado: (2020)

Antivirals/glucocorticoids: Diabetes mellitus and ALT elevation following off-label use in COVID-19: case report
Publicado: (2020)

Multiple drugs: Lack of efficacy in COVID-19 pneumonia and off label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia, off-label use and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report
Publicado: (2022)

Antibacterials/corticosteroids/dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2021)

Antibacterials/interferon/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Bamlanivimab: Gene mutation in COVID-19 infection and off label use: case report
Publicado: (2022)

Antivirals: Repolarisation and conduction disorder following off-label use: 2 case reports
Publicado: (2021)

Multiple drugs: COVID-19-pneumonia, off-label use and lack of efficacy: 2 case reports
Publicado: (2021)

Chloroquine/favipiravir/rituximab: COVID-19-pneumonia, off-label use and lack of efficacy: case report
Publicado: (2022)

Tocilizumab: Lobar pneumonia following off label use: case report
Publicado: (2020)

Rituximab: Adenovirus pneumonia following off-label use: case report
Publicado: (2021)

Antibacterials/immune-globulin/methylprednisolone: Lack of efficacy and off label use: case report
Publicado: (2021)

Antivirals/fluoroquinolones: Prolongation of QTc interval following off-label use: 9 case reports
Publicado: (2021)

Antibacterials/hydrocortisone/oseltamivir: Primary gastric mucormycosis following off label use: case report
Publicado: (2021)

Multiple drugs: Carbapenem-resistant Klebsiella pneumoniae infection due to off-label use: 9 case reports
Publicado: (2021)

Antivirals/corticosteroids/withania somnifera: Rhino-orbital mucormycosis and off label use: 13 case reports
Publicado: (2022)

Azithromycin/antiretrovirals/tacrolimus: Acute kidney injury following off-label use and interaction, and COVID-19 pneumonia: case report
Publicado: (2020)

Multiple drugs: Protracted severe COVID-19 pneumonia, hepatotoxicity and lack of efficacy following off label use: case report
Publicado: (2022)

Antivirals/interferon-α-1b: Elevated aminotransferases and vomiting following off-label use: case report
Publicado: (2021)

Dexamethasone: Pneumocystis jirovecii pneumonia and methicillin-resistant Staphylococcus aureus endocarditis following the off-label use: 2 case reports
Publicado: (2022)

Amphotericin-B-liposomal/antibacterials/immunosuppressants: Various infections, nephrotoxicity and off-label use: 4 case reports
Publicado: (2022)

Multiple drugs: Pneumocystis jirovecii pneumonia following off label use and hypersensitivity: case report
Publicado: (2022)

Amoxicillin/clavulanic-acid/dexamethasone/piperacillin/tazobactam: Lack of efficacy during off-label treatment of COVID-19 pneumonia: case report
Publicado: (2022)

Antivirals/direct oral anticoagulants interaction: Anticoagulation drug level increased and off label use: 12 case reports
Publicado: (2020)

Off-Label Use of Ceftazidime/Avibactam for the Treatment of Pan-Drug-Resistant Klebsiella pneumoniae in a Neonate: Case Report and Literature Review
por: Mangarov, Iliya, et al.
Publicado: (2023)

Multiple drugs: Pancytopenia, COVID-19 and off-label use: case report
Publicado: (2020)

Multiple drugs: COVID-19 and off-label use: 2 case reports
Publicado: (2020)

Multiple drugs: COVID-19 infection and off-label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 and off-label use: 22 case reports
Publicado: (2021)

Multiple durgs: COVID-19 infection and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Derangement of liver function tests, pneumocystis pneumonia and off-label use: case report
Publicado: (2022)

Anti-bacterial/heparin/hydroxychloroquine: Off label use and resistance: case report.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3a88vsvv156sj0qvnjgsarcs6i